Biblio Discovery — Demo Discovery Service

229 hasil untuk "Steven G Deeks"

Menampilkan 1–20 · 0,22 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Transmitted minority drug-resistant HIV variants: a new epidemic?

    Steven G Deeks

    PLoS Medicine, Vol. 5 No. 7 · 2008 · Inggris · DOAJ Scopus

    Steven Deeks discusses a new study that investigates the prevalence and clinical implications of transmitted minority drug-resistant HIV variants.

    Juga tersedia di: PLOS

  2. Artikel Jurnal Teks lengkap

    HIV control: Is getting there the same as staying there?

    Philip Goulder; Steven G Deeks

    PLoS Pathogens, Vol. 14 No. 11 · 2018 · Inggris · DOAJ Scopus

    In this brief review and perspective, we address the question of whether the immune responses that bring about immune control of acute HIV infection are the same as, or distinct from, those that maintain long-term viral suppression once control of viremia has been achieved. To this end, we describe…

    Juga tersedia di: PLOS

  3. Artikel Jurnal

    Biomarker reveals HIV's hidden reservoir

    Leslie R Cockerham; Steven G Deeks

    eLife, Vol. 3 · 2014 · Inggris · DOAJ

    Determining the total amount of HIV DNA in people undergoing antiretroviral therapy could accelerate the development of novel therapies and potential cures for HIV infection.

  4. Artikel Jurnal

    Maximising the global health impact of future HIV cure-related interventions through advance planning

    Regina Brown; Steven G. Deeks; Nir Eyal

    Journal of Virus Eradication, Vol. 4 No. 3 · 2018 · Inggris · DOAJ Scopus

    Thinking about public health impact should inform HIV curative investigations. Should an effective HIV cure or sustained viral remission intervention emerge from ongoing investigations, implementation strategies aimed at ensuring global access will be needed if these approaches are to be impactful…

  5. Artikel Jurnal Teks lengkap

    The end of HIV: Still a very long way to go, but progress continues.

    Steven G Deeks; Sharon R Lewin; Linda-Gail Bekker

    PLoS Medicine, Vol. 14 No. 11 · 2017 · Inggris · DOAJ Scopus

    In an Editorial accompanying PLOS Medicine's Special Issue on Advances in Prevention, Treatment and Cure of HIV/AIDS, Guest Editors Steven Deeks, Sharon Lewin, and Linda-Gail Bekker discuss priorities in the field and the content of the issue.

    Juga tersedia di: PLOS

  6. Artikel Jurnal

    Comprehensive synergy mapping links a BAF- and NSL-containing “supercomplex” to the transcriptional silencing of HIV-1

    Zichong Li; Steven G. Deeks; Melanie Ott dkk.

    Cell Reports, Vol. 42 No. 9 · 2023 · Inggris · DOAJ Scopus

    Summary: Host repressors mediate HIV latency, but how they interactively silence the virus remains unclear. Here, we develop “reiterative enrichment and authentication of CRISPRi targets for synergies (REACTS)” to probe the genome for synergies between HIV transcription repressors. Using eight…

  7. Artikel Jurnal Teks lengkap

    Mechanisms of long COVID and the path toward therapeutics

    Michael J. Peluso; Steven G. Deeks

    Cell · 2024 · Inggris · OpenAlex Scopus

    Long COVID, a type of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PASC) defined by medically unexplained symptoms following infection with SARS-CoV-2, is a newly recognized infection-associated chronic condition that causes disability in some people…

  8. Artikel Jurnal Teks lengkap

    The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.

    Michael Rosenblum; Steven G Deeks; Mark van der Laan dkk.

    PLoS ONE, Vol. 4 No. 9 · 2009 · Inggris · DOAJ Scopus

    BACKGROUND:We hypothesized that the percent adherence to antiretroviral therapy necessary to maintain HIV suppression would decrease with longer duration of viral suppression. METHODOLOGY:Eligible participants were identified from the REACH cohort of marginally housed HIV infected adults in San…

    Juga tersedia di: PLOS

  9. Artikel Jurnal

    Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIV

    Deepti Kannan; Eric Wang; Steven G. Deeks dkk.

    Cell Reports, Vol. 44 No. 11 · 2025 · Inggris · DOAJ Scopus

    Summary: Antiretroviral therapy (ART) inhibits human immunodeficiency virus (HIV) replication to maintain undetectable viral loads but does not result in a cure. Due to the significant challenges of lifelong ART for many, there is a strong interest in therapeutic strategies that result in a cure…

  10. Artikel Jurnal

    Association between statin use, atherosclerosis, and mortality in HIV-infected adults.

    Binh An P Phan; Yifei Ma; Rebecca Scherzer dkk.

    PLoS ONE, Vol. 15 No. 4 · 2020 · Inggris · DOAJ Scopus

    BackgroundWhile HIV infection is associated with increased cardiovascular risk, benefit from statin is not well established in HIV-infected adults. We assessed whether statins are associated with a decrease in carotid artery intima-media thickness (cIMT) progression and all-cause mortality in…

  11. Artikel Jurnal

    Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency.

    Zichong Li; Jun Wu; Leonard Chavez dkk.

    PLoS Pathogens, Vol. 15 No. 1 · 2019 · Inggris · DOAJ Scopus

    The establishment of HIV-1 latency gives rise to persistent chronic infection that requires life-long treatment. To reverse latency for viral eradiation, the HIV-1 Tat protein and its associated ELL2-containing Super Elongation Complexes (ELL2-SECs) are essential to activate HIV-1 transcription…

  12. Artikel Jurnal Teks lengkap

    Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs.

    Basile Siewe; Jennillee Wallace; Sonya Rygielski dkk.

    PLoS ONE, Vol. 9 No. 4 · 2014 · Inggris · DOAJ Scopus

    During HIV infection, IL-10/IL-10 receptor and programmed death-1 (PD-1)/programmed death-1-ligand (PD-L1) interactions have been implicated in the impairment of cytotoxic T lymphocyte (CTL) activity. Despite antiretroviral therapy (ART), attenuated anti-HIV CTL functions present a major hurdle…